MEDICINOVA INC·4

Jan 11, 4:52 PM ET

Matsuda Kazuko 4

4 · MEDICINOVA INC · Filed Jan 11, 2024

Insider Transaction Report

Form 4
Period: 2024-01-09
Matsuda Kazuko
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2024-01-09+157,500157,500 total
    Exercise: $2.40From: 2024-01-09Exp: 2033-01-31Common Stock (157,500 underlying)
Footnotes (1)
  • [F1]On February 1, 2023, the reporting person was granted an option to purchase 225,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 157,500 shares.

Documents

1 file
  • 4
    ownership.xmlPrimary